| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8830938 | The American Journal of Surgery | 2017 | 25 Pages |
Abstract
AT did not improve survival, however was more commonly administered in advanced disease. Stage I patients had high recurrence rates but rarely received AT. Prospective evaluation of appropriate AT regimens and use in early stage patients should be considered.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
M.T. Chavez, J.P. Sharpe, T. O'Brien, K.T. Patton, D.C. Portnoy, N.A. VanderWalde, J.L. Deneve, D. Shibata, S.W. Behrman, P.V. Dickson,